NEW YORK, Aug. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/xray.
The investigation concerns whether XRAY and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On August 9, 2017, Dentsply revealed its second quarter 2017 earnings that were below its expectations, and an SEC investigation "concerning the Company's accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company." Following this news, Dentsply stock dropped $5.18 per share or 8.44% to close at $56.23 per share on August 9, 2017.
If you are aware of any facts relating to this investigation, or purchased shares of Dentsply, you can assist this investigation by visiting the firm's site: www.bgandg.com/xray. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | firstname.lastname@example.org
SOURCE Bronstein, Gewirtz & Grossman, LLC